SAN DIEGO, July 2, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (“Apricus Bio”) (Nasdaq:APRI) (www.apricusbio.com) announced today that Bassam Damaj, Ph.D., President and Chief Executive Officer, will present at the JMP Securities Healthcare Conference, being held at The Peninsula in New York City. Apricus Biosciences’ presentation will take place on July 12, 2012 at 12:00pm Eastern Time.
